HomeBUSINESS
BUSINESS

Alcohol Dependence Med Nalmefene Delivers Positive Japan Data: Otsuka/Lundbeck
(Jun.9.2017)

Otsuka Pharmaceutical and its Danish partner Lundbeck A/S released favorable topline data from a PIII comparative clinical trial and a follow-on, long-term extension study in Japan for their alcohol dependence drug nalmefene ...
(LOG IN FOR FULL STORY)

News Calendar